1 Phase III Trial of Bevacizumab in the Primary Treatment of Advanced Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer: A Gynecologic Oncology.
477_17
Phase III CORRECT trial of regorafenib in metastatic colorectal cancer ( mCRC )
Chapter 17 Audit Sampling for Tests of Details of Balances.
˜ 25% of breast cancer patients are pre- menopausal (15% pts
